The yearlong trial found that the new drug was able to reduce HbA1c levels more than Ozempic.

Doctors have recently seen a trend where significant weight loss can leave the feet looking bonier, looser, or more deflated.

The daily tablet delivered standout trial results, though a key trade-off could limit how widely it's eventually adopted.

Weight-loss drugs are linked to a slew of health benefits — but may not make you happy, study finds - ‘This is still a very ...

GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and flatter buttocks, surgeons say.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Millions of Americans on Medicare will have access to prescription weight loss medications for the first time starting July 1 ...

One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. While providers may prescribe this drug off label ...

Serena Williams' weight loss is, in part, due to her use of GLP1s.

Show More Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight loss medicines, ...